Acadia Pharmaceuticals | ACAD - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 11.33 1.25 2026-06
ALKERMES 135.81 96.48 2026-06
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Cara Therapeutics 0.49 27.28 2026-03
Corcept Therapeutics 188.23 74.66 2026-06
Eisai 26.55 9.06 2026-06
Eli Lilly 32.9 7.37 2026-06
Incyte 14.45 0.9 2026-06
J&J 29.43 4.9 2026-06
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 22.1 5.99 2026-06
Pfizer 11.48 2.16 2026-06
Prothena 22.11 11.37 2022-03
PTC Therapeutics 8.76 1.22 2026-03
Sarepta Therapeutics 27.27 0 2026-03
Vanda Pharmaceuticals 16.79 7.07 2023-06
Vertex Pharmaceuticals 28.05 2.22 2026-06